SynthesisJournal of gastroenterology2013

Meta-analysis: mortality and serious adverse events of peginterferon plus ribavirin therapy for chronic hepatitis C.

Tatsuya Minami et al.PubMed ↗Publisher ↗

No numbers read from the abstract.